Find your path to Janine
98 people in our graph share verified history with Janine — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedJanine: together at University of Amsterdam (1988–1992)
×6Janine: together at University of Amsterdam
Janine: together at Cartography Biosciences
×3Janine: together at Utrecht University
About
Janine Schuurman is a scientist and biotech consultant with a PhD in Molecular Immunology from the University of Amsterdam. She spent over two decades at Genmab beginning in 2000, where she contributed to the development of six FDA/EMA-approved therapeutic antibodies and co-invented platform technologies including DuoBody®, HexaBody®, and HexElect®, which underpin multiple approved therapies. She currently operates an independent consulting practice and serves on the Board of Directors of The Antibody Society, having held the positions of Vice President and President from 2022 to 2025.
Experience
- Lust for Life Science B.V.Independent Biotech Consultantcurrent2023 — present
- Laigo BioScientific Advisory Board membercurrent2026 — present
- Cartography BiosciencesScientific Advisory Board membercurrent2023 — present
- Commit BiologicsMember Board of Directorscurrent2025 — present
- Commit BiologicsScientific Advisory Board member (chair)current2025 — present
- Commit BiologicsScientific Advisor2024 — 2025
- FairJourney BiologicsScientific Advisory Board member (chair)current2024 — present
- AbTherxScientific Advisorcurrent2024 — present
- Bioqube VenturesAdvisorcurrent2023 — present
- Oncode InstituteInvestment Advisory Committee membercurrent2021 — present
- The Antibody SocietyMember Board of Directorscurrent2020 — present
- The Antibody SocietyPresident2024 — 2025
- The Antibody SocietyVice President2022 — 2023
- GenmabSenior Vice President, Head Antibody Research & Technology2021 — 2023
- GenmabCorporate Vice President Antibody Research and Technology2018 — 2021The Netherlands
- GenmabVice President Research2014 — 2017Utrecht, Netherlands
- GenmabDirector Strategic Research2011 — 2013
- GenmabAssociate Director Research2000 — 2010
- Keystone Symposia on Molecular & Cellular BiologySAB member2019 — 2023
- Utrecht UniversityPostdoctoral Research Fellow1998 — 2000
- SanquinPostdoctoral Research Fellow1997 — 1998
- SanquinPhD student1992 — 1997
Skills & more
Thought LeadershipCross-functional Team LeadershipAntibody EngineeringBiotechnology25Drug Development10Lifesciences16Monoclonal Antibodies17Life Sciences10Molecular Biology12Biopharmaceuticals8Immunology18Drug Discovery12
+7 more
Clinical DevelopmentAntibodiesTechnology TransferBiochemistryTherapeutic Antibody DiscoveryAntibody SciencePharmaceutical IndustryFrom Janine's professional profile.
Colleagues at Bioqube Ventures
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Joris De Maeyer
Executive in Residence at Bioqube Ventures
Frequently asked questions
- Who is Janine Schuurman?
- Janine Schuurman is a scientist and biotech consultant with a PhD in Molecular Immunology from the University of Amsterdam. She spent over two decades at Genmab beginning in 2000, where she contributed to the development of six FDA/EMA-approved therapeutic antibodies and co-invented platform technologies including DuoBody®, HexaBody®, and HexElect®, which underpin multiple approved therapies. She currently operates an independent consulting practice and serves on the Board of Directors of The Antibody Society, having held the positions of Vice President and President from 2022 to 2025.
- Where does Janine Schuurman work?
- Janine Schuurman is Senior Advisor at Bioqube Ventures.
- Where did Janine Schuurman go to school?
- Janine Schuurman studied at University of Amsterdam (Doctor of Philosophy - PhD, Immunology); University of Amsterdam (Medical Biology).
Same school
Also attended University of Amsterdam284
Job van der VoortCo-founder & CEO of RemoteMartijn KleijwegtInvestor at LSP (Life Sciences Partners)René KuijtenInvestor at LSP (Life Sciences Partners)TorjusInvestor at InvestinorDamien van der BijlInvestment Director at Capricorn Venture PartnersAndrea van ElsasInvestor at Third Rock Ventures
+ 278 more
Shared employers
Also worked at Oncode Institute6
René KuijtenInvestor at LSP (Life Sciences Partners)Teri WilleyP2C Managing Director & Officer at Pathway to CuresRudy DekeyserPartner, Head of Health Economic Funds at EQT Life SciencesRene KuijtenHead of EQT Life Sciences at EQT Life SciencesMarkwin VeldersAdvisory Committee member at Curie CapitalRudy DekeyserGeneral Partner at EQT Health Economics Cooperatief
Also worked at Genmab3
Also worked at Keystone Symposia on Molecular & Cellular Biology2
Also worked at Utrecht University31
René KuijtenInvestor at LSP (Life Sciences Partners)Erik MeijerVenture Scout at Storm VenturesLaura LentzExecutive Assistant at Castle Island VenturesPim SwartAssociate Partner at Maven 11Pablo BilusInvestment Analyst at Maven 11Tea EleziGeneral Partner at Peak
+ 25 more